Our CEO Robert Galarza explains how we’re going to integrate our technology with Sigma and talks about our partnership with Deloitte.
View the full interview by playing video below.
We were honored to be a part of this panel during the Cantech Investment Conference this year.
Robert Galarza, our CEO, got the opportunity to present BLOCKStrain and explain why genetic verification is important and how testing will bring integrity to the industry.
Find out what the what problems the industry faces now and the solutions that we’ve been working on.
CEO Robert Galarza describes his company as “23andMe for the cannabis industry.”
He emphasizes the importance of product consistency and establishing consistent strain identities, especially in the medical cannabis space. BLOCKStrain’s technology can help LPs achieve product consistency and the company offers value-added services such as providing LPs with genetic data to track plant evolution. By creating a cannabis registry, BLOCKStrain technology helps distinguish legal cannabis from illicit sources. BLOCKStrain generates revenue through its cannabis testing program.